|
|
Retrospective Cohort (N=157) |
SpHb Group (N=170) |
Standard Care Group (N=157) |
| |
|
Total* |
|
Total* |
|
Total* |
| Age (years), Mean (SD) |
61.0 (15.4) |
157 |
61.9 (15.9) |
170 |
61.0 (15.8) |
157 |
| ASA Status, N (%) |
|
|
|
|
|
|
| 1 |
10 (6.4) |
157 |
19 (11.1) |
170 |
8 (5.1) |
157 |
| 2 |
111 (70.7) |
157 |
107 (62.9) |
170 |
116 (73.9) |
157 |
| 3 |
35 (22.3) |
157 |
43 (25.2) |
170 |
30 (19.1) |
157 |
| 4 |
1 (0.6) |
157 |
1 (0.6) |
170 |
3 (1.9) |
157 |
| Male, N (%) |
84 (53.5) |
157 |
82 (48.2) |
170 |
84 (53.5) |
157 |
| Laboratory Hb value (g/dL), Mean (SD)a |
- |
- |
13.5 (1.6) |
155 |
13.6 (1.5) |
147 |
| Surgical Procedure, N (%)b |
| Hip Replacement |
- |
- |
55 (32.4) |
170 |
52 (33.1) |
157 |
| Knee Replacement |
- |
- |
56 (32.9) |
170 |
42 (26.8) |
157 |
| Spine Surgery |
- |
- |
21 (12.4) |
170 |
22 (14.0) |
157 |
| Incision and Drainage |
- |
- |
4 (2.4) |
170 |
9 (5.7) |
157 |
| Shoulder Surgery |
- |
- |
6 (3.5) |
170 |
8 (5.1) |
157 |
| Other |
- |
- |
28 (16.5) |
170 |
46 (29.3) |
157 |
|
*Total refers to the number of patients for whom relevant data was available (e.g. responded to follow up).
a Preoperative laboratory Hb values unavailable for the Retrospective Cohort
b Surgical procedure data unavailable for the Retrospective Cohort. Other includes ankle, femur, tibia, Achilles tendon, humerous, elbow, hallux valgus, calcaneous, tibial, and wrist repairs; tumor and hardware removal, and leg tendon transplants. |
| Table 1: Characteristics of patients in the Retrospective Cohort, Standard Care Group, and SpHb Group. |
